Literature DB >> 3717245

Uveal melanoma necrosis after helium ion therapy.

D F Goodman, D H Char, J B Crawford, R D Stone, J R Castro.   

Abstract

A 71-year-old man underwent enucleation because of intractable pain ten months after receiving helium ion therapy for a uveal melanoma. There was no clinical or ultrasonographic evidence of tumor regression but histologically the tumor appeared almost entirely necrotic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3717245     DOI: 10.1016/0002-9394(86)90762-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

Review 1.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

2.  Is radiation a justifiable treatment of choroidal melanoma?

Authors:  J A Oosterhuis; P K Lommatsch; A Wessing
Journal:  Br J Ophthalmol       Date:  1988-04       Impact factor: 4.638

3.  Development and validation of a patient based measure of outcome in ocular melanoma.

Authors:  A J Foss; D L Lamping; S Schroter; J Hungerford
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

4.  Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

Authors:  A J Foss; I Whelehan; J L Hungerford; D F Anderson; R D Errington; A Kacperek; M Restori; J Kongerud; M Sheen
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

5.  Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

Authors:  H Klaus; P K Lommatzsch; U Fuchs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.

Authors:  E Messmer; N Bornfeld; M Foerster; H Schilling; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.